HOME >> MEDICINE >> NEWS
Implantable device pumps up ailing heart

DALLAS, May 14 In one of the longest follow-up studies of an implantable left ventricular assist device, heart failure patients reported a substantially improved quality of life, according to a report in todays rapid access issue of Circulation: Journal of the American Heart Association.

Two research teams reported the study, which included four British patients. Three of them are still alive after an average of 3 months from implantation of the device. All were considered ineligible for heart transplants due to their age and poor kidney function.

The device includes the pump itself and a battery pack that lasts eight hours between recharges. The pack is worn at the waist or carried in a small shoulder bag. The batteries are attached through a cable that plugs into a small pedestal-shaped electrical unit implanted in the skull behind the ear. The pump has a small controller box that can be use to adjust for high and low activity levels.

One patient, the second to get the device, developed a brain hemorrhage under the electrical pedestal. Although the hemorrhage was successfully treated, he remained on a ventilator, suffered right heart failure and died about three months after receiving the pump. Subsequently, skull thickness was measured by computerized tomography and the surgical technique was modified to prevent such penetration.

The other patients went home three to eight weeks after receiving the pump and returned to normal activities. There were no infections or blood clots reported in or near the device.

This small, simple, safe pump can be implanted with little or no time on a heart-lung machine. It poses very little risk and can boost the patients native heart function, says O.H. Bud Frazier, M.D., chief of cardiopulmonary transplantation and director of surgical research at the Texas Heart Institute and chief of transplant services at St. Lukes Episcopal Hospital in Houston. The device, called the Jarv
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
13-May-2002


Page: 1 2 3

Related medicine news :

1. Implantable heart defibrillators
2. Statement: Implantable medical identification chip
3. Implantable cardiac defibrillator use significantly lowers heart failure mortality
4. Implantable defibrillators cost-effective for preventing sudden death
5. Implantable heart device reduces deaths by one-third
6. Implanted devices detect high-risk heart failure patients
7. Columbia study shows widely used artery clearing device does not help patients during heart attack
8. New device will help stroke victims recovery
9. Florida Tech scientist wins patent for device to deliver X-ray irradiation
10. New guidelines conclude all aerosol therapy devices equally effective
11. Entrepreneurism Center at UC San Diego funds commercialization of lung, shock, other devices

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Implantable device pumps ailing heart

(Date:5/22/2015)... May 22, 2015 “It’s like ... SLP, RAC-CT, CHHRP-QT, Vice President of Clinical Operations/Education ... important ‘language’ that impacts how care is coded ... in long term care reimbursement, operations and compliance ... and talent management, launches a new series of ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Coordinating ... a difficult process. Historically providers have not been ... payers. Starting in 2015, Medicare has paved the ... activities. Thanks to the launch of Oculus ... and health systems using the platform will now ...
(Date:5/22/2015)... May 22, 2015 Power Systems is proud ... the 2015 race season. Drobeck is in his second year ... a firefighter with the Missoula Fire Department in Missoula, MT. ... Pro in 2014. During his career, he has had 15 ... Drobeck recorded top 10 finishes in all seven of his ...
(Date:5/22/2015)... Philadelphia, PA (PRWEB) May 22, 2015 According ... as a hub for drug related death, totaling almost 2,500 ... number, as reported by state officials, totals 2,489 deaths stemming ... numbers work out, Pennsylvania loses seven people every day to ... Philadelphia has been singled out as one of the most ...
(Date:5/22/2015)... May 22, 2015 Medivo, Inc., a leader ... Rates and Genotype Results in ‘Baby Boomers’ Screened for HCV ... Nationwide Lab Test Database” at Digestive Disease Week, May 16-19, ... Affairs and Analytics team members Carol Smyth, MB; Jason Bhan, ... Parker, MSI, along with Nancy Reau, MD from the University ...
Breaking Medicine News(10 mins):Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2
(Date:5/22/2015)... May 22, 2015 The leading companies ... billion global cardiac rhythm management device market dominate ... that Medtronic, St. Jude Medical, Boston Scientific and ... this market segment. The healthcare market research publisher,s ... uses 2015 as a base year, providing forecasts ...
(Date:5/22/2015)... ROCKVILLE, Md. , May 22, 2015 /PRNewswire/ ... "RegeneRx") today announced a peer-reviewed publication of the ... study evaluating RGN-259 (RegeneRx,s preservative-free eye drops) for ... Inc.,s controlled adverse environment (CAE ® ) model.  ... and the results, which were previously disseminated by ...
(Date:5/22/2015)... May 22, 2015 Research and Markets ... of the "Latest Regulations on Pharmaceutical International ... their offering. This is first time ... guidance on international multi-center clinical trials of drugs ... begun to be implemented on March 1, 2015. ...
Breaking Medicine Technology:Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
Cached News: